4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-045474
CEO, CFO, Director acquired 5,559 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-12-11 | Option exercise | +5,559 | 63,340 | D | ||
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-12-11 | Option exercise · Restricted Stock Units | −5,559 | 55,583 | D | ||
Loading xslF345X05/ownership.xml…